News

Biossmann Snags AI Thought-Leader Pankaj Kedia as its First Chief AI Officer and Board Member to Fuel the Next Phase of Growth

Sets groundwork for global expansion and transformation into a medical solutions powerhouse with AI-based innovations MEXICO CITY and SAN DIEGO, May 23, 2024 /PRNewswire/ — Biossmann today announced that it is bringing on board renowned […]

No Picture
News

Medtronic study shows navigated bronchoscopy can avoid needle biopsy complications in diagnoses of lung cancer

A head-to-head study from Medtronic showed that its minimally invasive approach to reaching tissues in the lung suspected of harboring cancer could be just as effective as the current standard of care biopsy—which requires guiding […]

BioSpace

Takeda Joins Hot Molecular Glue Market With $1.2B Deal

Published: May 23, 2024 By Tristan Manalac Pictured: Facade of Takeda’s office in Massachusetts/iStock, hapabapa Takeda Pharmaceuticals has inked an exclusive licensing deal with China-based Degron Therapeutics to develop novel molecular glue degraders for various […]

News

New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA)

– Results across NEURO-TTRansform subgroups show consistent benefit in neuropathy impairment and improved quality of life, regardless of patient segmentation – CARLSBAD, Calif., May 23, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today […]

No Picture
News

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

St Andrews, UK – 23nd May 2024 – Pneumagen, a clinical stage biotech company developing Neumifil (HEX17), a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), presented positive […]

No Picture
News

Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference

Corporate presentation scheduled for Tuesday, 04 June 2024 at 4:00 PM PT SAN DIEGO and SEOUL, South Korea, May 23, 2024 /PRNewswire/ — Bionoxx Inc., an innovative biotech company developing neutrophil-directed T cell modulation technology, […]

No Picture
News

Provenance Bio Announces Results for Recombinant Protein Demonstrating Cell Adhesion Functionality that Can Replace Animal-Derived Proteins

SAN DIEGO, May 22, 2024 /PRNewswire/ — Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of function by matching the cell adhesion strength of fibronectin, providing […]

No Picture
News

Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma

SAN DIEGO, CA and TAICANG, China, May 22, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients […]

News

“EMBRACING INTERNATIONAL ALLIANCES” SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024

ZURICH, May 22, 2024 /PRNewswire/ — Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the […]

No Picture
News

Inipharm to Present Pharmacokinetic Data From a Phase 1 Clinical Trial of INI-822, a Small Molecule Inhibitor of HSD17B13

BELLEVUE, Wash. & SAN DIEGO–(BUSINESS WIRE)–Inipharm, a biopharmaceutical company focused on developing therapies for fibrotic liver diseases, today announced upcoming presentations of clinical and preclinical data from INI-822, the company’s Phase 1 small molecule inhibitor […]

No Picture
News

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the closing […]

No Picture
News

Neurocrine Biosciences Announces Publication of Phase 3 KINECT®-4 Post Hoc Analysis Demonstrating Clinically Meaningful and Sustained Improvement in Tardive Dyskinesia With Long-Term Use of INGREZZA® (valbenazine) Capsules

SAN DIEGO, May 21, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT®-4 study of INGREZZA® (valbenazine) capsules in the […]

News

A New Gene-Editing System Tackles Complex Diseases

Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the UC San Diego have developed new, efficient genome […]

No Picture
News

Phytoplankton Genetically Sequenced at Sea for the First Time

LOS ANGELES–(BUSINESS WIRE)–Viking® (www.viking.com) (NYSE: VIK) today announced its latest scientific advancement on board the company’s expedition fleet with the addition of real-time environmental DNA (eDNA) sequencing of phytoplankton. With scientific support from UC San […]

News

Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®

Updated Prescription Drug User Fee Act?goal date of December 29, 2024 SAN DIEGO, May 21, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Bristol Myers Squibb was reassigned a Prescription Drug […]